1 – 10 of 166
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Re : Joshua J. Meeks. Urothelial Cancer: What Is the Role of Expression-based Subtypes to Guide Neoadjuvant Therapy in Muscle-invasive Bladder Cancer? Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.11.014
(2026) In European Urology Focus
- Contribution to journal › Letter
- 2025
-
Mark
Bladder cancer subtypes exhibit limited plasticity across different microenvironments and in metastases
- Contribution to journal › Article
-
Mark
Evaluation of gene expression-based predictors of lymph node metastasis in bladder cancer
- Contribution to journal › Article
- 2024
-
Mark
Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer
- Contribution to journal › Article
-
Mark
Molecular Subtypes Are Associated With Clinical Benefit in Cisplatin-Treated Metastatic Urothelial Cancer Patients
- Contribution to journal › Article
-
Mark
International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer - Principles of Classification and Emerging Clinical Utility
- Contribution to journal › Article
- 2023
-
Mark
The Lund taxonomy for bladder cancer classification – from gene expression clustering to cancer cell molecular phenotypes, and back again
- Contribution to journal › Scientific review
-
Mark
Tumor Biomarkers for Bacillus Calmette-Guérin Response : What We Get Is Not What We Want
- Contribution to journal › Debate/Note/Editorial
-
Mark
Restoring tumor immunogenicity with dendritic cell reprogramming
- Contribution to journal › Article
-
Mark
Re : Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020
- Contribution to journal › Letter
